Shionogi says COVID pill trial shows reduction in symptoms
Japan’s Shionogi & Co Ltd said on Wednesday its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared with a placebo in a Phase III trial in Asia.
Related Articles
UnitedHealth takes $872 million hit to profit from Change Healthcare hack
UnitedHealth Group said on Tuesday it was expecting to take a hit of up to $1.6 billion this year related to a data breach at…
UnitedHealth takes $872 million hit to profit from Change Healthcare hack
UnitedHealth Group said on Tuesday it was expecting to take a hit of up to $1.6 billion this year related to a data breach at…
Best Surgeons & Hospitals Research All-Stars
Healthcare data analytics for detailed cost analysis, evaluation of clinical operations, and optimization of patient outcomes.
Best Surgeons & Hospitals Research All-Stars
Healthcare data analytics for detailed cost analysis, evaluation of clinical operations, and optimization of patient outcomes.
Recipient of world’s first pig kidney transplant discharged from Boston hospital
The recipient of the world’s first pig kidney transplant is heading home from Massachusetts General Hospital Wednesday, nearly two weeks after the surgery.
Senate probes private-equity’s role in ED staffing
“Senate committee investigates private equity-owned hospital emergency departments and their impact on patient safety and care, requesting information from top
Roxana Mehran, MD, MSH ’95: 2024 Jacobi Medallion Recipient
Dr. Roxana Mehran was honored Thursday, March 14, 2024 with the Jacobi Medallion at the 2024 Jacobi Medallion Ceremony at The Plaza Hotel.This prestigious aw…
Some women on Ozempic report getting unexpectedly pregnant
Weight-loss drugs like Ozempic and Wegovy can help people shed pounds and regulate blood sugar but some people say they are also getting pregnant while…
March 2024: Art and Arteries
Shelley Wood talks painting, science, tragedy, and woo-woo with C. Michael Gibson.
March 2024: Art and Arteries
Shelley Wood talks painting, science, tragedy, and woo-woo with C. Michael Gibson.